This compound is primarily utilized in the field of biomedical research, particularly in targeted protein degradation studies. It serves as a key component in the development of PROTACs (Proteolysis Targeting Chimeras), which are designed to selectively degrade specific proteins within cells. By binding to both the target protein and an E3 ubiquitin ligase, it facilitates the ubiquitination and subsequent degradation of the protein of interest. This application is crucial in understanding disease mechanisms, especially in cancer research, where it helps in identifying and validating potential therapeutic targets. Additionally, it aids in the exploration of protein function and signaling pathways, providing insights into cellular processes and potential drug development strategies.